[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351568-105":59,"doc-detail-351568-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","navigating-the-tumor-microenvironment-in-colorectal-liver-metastasis-barriers-to-therapy-and-emerging-opportunities","Navigating the Tumor Microenvironment in Colorectal Liver Metastasis: Barriers to Therapy and Emerging Opportunities","","Liver metastases from colorectal cancer (CRC) drive poor outcomes and are tightly linked to the liver’s tumor microenvironment (TME), yet TME research for liver metastases lags behind primary tumor studies. This review synthesizes advances in organ-specific TME biology for colorectal liver metastases (CRLM), covering key cellular players (TAMs, CAFs, MDSCs) and non-cellular elements (ECM, soluble factors). It analyzes how TME mechanisms create pre-metastatic niches, support colonization, enable immune escape, and induce drug resistance, then evaluates TME-targeted therapeutic remodeling strategies and combination approaches to improve anti-metastatic treatment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/navigating-the-tumor-microenvironment-in-colorectal-liver-metastasis-barriers-to-therapy-and-emerging-opportunities/351568/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/navigating-the-tumor-microenvironment-in-colorectal-liver-metastasis-barriers-to-therapy-and-emerging-opportunities/351568.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why does the tumor microenvironment matter in colorectal liver metastasis?","Question",{"text":113,"@type":114},"The liver’s TME shapes progression and treatment response in CRLM. Its cellular and non-cellular components coordinate immune suppression, colonization, and resistance mechanisms.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which TME components does the review highlight for CRLM?",{"text":118,"@type":114},"It emphasizes tumor-associated macrophages, cancer-associated fibroblasts, and myeloid-derived suppressor cells, along with extracellular matrix and soluble factors that support tumor-host interactions.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the TME contribute to therapy resistance in CRLM?",{"text":122,"@type":114},"The review links TME-driven heterogeneity, pre-metastatic niche establishment, immune evasion, and evolving stromal and matrix conditions to reduced treatment efficacy and drug resistance.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351568,1790145714,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Tech Science Press  \n[https://doi. org/10.32604/or.2026.076013](https://doi. org/10.32604/or.2026.076013)  \nREVIEW  \nNavigating the Tumor Microenvironment in Colorectal Liver Metastasis: Barriers to Therapy and Emerging Opportunities  \nPengtao Hu1, Junjie Sun1, Jian Lu2, Chunlei Ge3, Hanzhi Sun1 and Chengyu Lv1, *  \n1 Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China 2 International Oncology Institute, the First Affiliated Hospital of Zhejiang Chinese Medical University, Oncology Department of the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China 3 Department of General Surgery, Gaochun Hospital of Traditional Chinese Medicine, Nanjing, China  \n*Corresponding Author: Chengyu Lv. Email: [lcy_1234@aliyun.com](lcy_1234@aliyun.com)  \nReceived: 12 November 2025; Accepted: 20 February 2026; Published: 22 April 2026  \nABSTRACT: Liver metastases from colorectal cancer (CRC) are a primary cause of poor patient prognosis, closely linked to the liver’s unique tumor microenvironment (TME) . Compared to primary tumors, research on the TME of liver metastases remains insufficient. This review systematically summarizes recent advances in TME research concerning colorectal liver metastases (CRLM), emphasizing its organ-specific characteristics, pivotal role in tumor progression, and influence on treatment response. We delve into the intricate cellular components of the TME—including tumor-associated macrophages, cancer-associated fibroblasts, and myeloid-derived suppressor cells—and non-cellular constituents such as the extracellular matrix and soluble factors. Furthermore, we explore the multifaceted mechanisms which the TME drives CRLM progression through establishing pre-metastatic niches, facilitating cancer cell colonization, mediating immune evasion, and inducing drug resistance. Additionally, we evaluate therapeutic strategies targeting the TME, including opportunities and challenges in remodeling cellular components, modulating the extracellular matrix, and developing combination therapies. Ultimately, this review aims to provide theoretical foundations and novel insights for developing more effective anti-metastatic therapies, with the goal of improving the prognosis for CRLM patients.  \nKEYWORDS: Colorectal cancer; liver metastasis; tumor microenvironment; pre-metastatic niche; immunosuppression; targeted therapy  \n1 Introduction  \nColorectal cancer (CRC) is the third most prevalent malignancy worldwide and the second leading cause of cancer-related mortality [1]. Despite the gradual improvement in the prognosis of patients diagnosed with CRC in high-income countries over the past several decades, metastatic CRC (mCRC) remains associated with a dismal survival rate of less than 15% with the liver being the most common site of metastasis [2,3] . Although some patients with colorectal cancer liver metastases (CRLM) may benefit from therapies that target the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR)-targeted signaling pathways, surgery is the only treatment that has the potential to cure colorectal liver metastases [4] . In recent studies, immune checkpoint inhibitors (ICIs) have demonstrated substantial clinical benefits in CRCs with high microsatellite instability or mismatch repair deficiencies [5,6] . This progress shows the great potential of therapies that target the tumor microenvironment (TME) . This field has begun to understand the critical factors that determine mCRC (Fig. 1) .  \nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nFigure 1: Schematic representation of tumor microenvironment components in colorectal cancer liver metastases. The core composition ofTME includes","cbCaisGfzn5vZkvX","https://ap.wps.com/l/cbCaisGfzn5vZkvX","pdf",6726811,26,"English","# Introduction\n# Tumor microenvironment biology in CRLM\n## Cellular components\n## Non-cellular components\n# Mechanisms driving CRLM progression\n## Pre-metastatic niche formation\n## Cancer cell colonization\n## Immune evasion\n## Drug resistance\n# Therapeutic strategies targeting the TME\n## Opportunities and challenges\n## Combination therapies","[{\"question\":\"Why does the tumor microenvironment matter in colorectal liver metastasis?\",\"answer\":\"The liver’s TME shapes progression and treatment response in CRLM. Its cellular and non-cellular components coordinate immune suppression, colonization, and resistance mechanisms.\"},{\"question\":\"Which TME components does the review highlight for CRLM?\",\"answer\":\"It emphasizes tumor-associated macrophages, cancer-associated fibroblasts, and myeloid-derived suppressor cells, along with extracellular matrix and soluble factors that support tumor-host interactions.\"},{\"question\":\"How does the TME contribute to therapy resistance in CRLM?\",\"answer\":\"The review links TME-driven heterogeneity, pre-metastatic niche establishment, immune evasion, and evolving stromal and matrix conditions to reduced treatment efficacy and drug resistance.\"}]","Navigating the Tumor Microenvironment in Colorectal Liver Metastasis: Barriers to Therapy and Emerging Opportunities | PDF",1790094740,66,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f58e766796db6b0954cf5cb1dcd99dbc.webp",983,1271,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d3df1fb6b9d6ed70909915536565777.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a149f6d18cbadb0a5c63083ea77e7f8f.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4c9c479c4e9d254114348a2c5bbd536.webp",980,1267]